BioCentury
ARTICLE | Company News

Abpro, Massachusetts General Hospital deal

May 30, 2016 7:00 AM UTC

Abpro and the hospital partnered to discover and co-develop mAbs in cancer, inflammation and autoimmunity. The partners will use Abpro’s DiversImmune antibody discovery platform. Abpro will have comme...